Summary
For Year 2026-27, Dr Lalchandani Labs reports the following shareholding: Total Promoters at 32.9%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0%, Domestic Institutional Investors at 0%, and Retail at 67.1%. This breakdown provides a quick snapshot of ownership distribution for Dr Lalchandani Labs in 2026-27.
Dr Lalchandani Labs FAQs
As of 04-2026, the promoter shareholding in Dr Lalchandani Labs stands at 32.9% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Dr Lalchandani Labs is 0% and 0% respectively.
The retail shareholding of the Dr Lalchandani Labs is 67.1%.
Changes in shareholding patterns of Dr Lalchandani Labs can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Dr Lalchandani Labs are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Dr Lalchandani Labs Associated Pages
